CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-20 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise | +4,680 | 110,879 | ||
| 2024-02-20 | Brown Iain Michael SVP, Chief Financial Officer | Shares withheld for taxes | −1,725 | $30.39 | $52K | 109,154 |
| 2024-02-20 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise · Restricted Stock Unit Award | −4,680 | 0 | ||
| 2024-02-18 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise | +2,034 | 5,934 | ||
| 2024-02-18 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Shares withheld for taxes | −706 | $32.18 | $23K | 5,228 |
| 2024-02-18 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise · Restricted Stock Unit Award | −2,034 | 4,067 | ||
| 2024-02-18 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise | +6,355 | 68,161 | ||
| 2024-02-18 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −1,869 | $32.18 | $60K | 66,292 |
| 2024-02-18 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise · Restricted Stock Unit Award | −6,355 | 12,709 | ||
| 2024-02-18 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Option exercise | +4,448 | 273,192 | ||
| 2024-02-18 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Shares withheld for taxes | −1,308 | $32.18 | $42K | 271,884 |
| 2024-02-18 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −4,448 | 8,897 | ||
| 2024-02-18 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise | +8,897 | 148,842 | ||
| 2024-02-18 | Jackson Blair Curtis EVP, Chief Operating Officer | Shares withheld for taxes | −3,888 | $32.18 | $125K | 144,954 |
| 2024-02-18 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise · Restricted Stock Unit Award | −8,897 | 17,793 | ||
| 2024-02-18 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise | +8,897 | 96,834 | ||
| 2024-02-18 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −3,951 | $32.18 | $127K | 92,883 |
| 2024-02-18 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise · Restricted Stock Unit Award | −8,897 | 17,793 | ||
| 2024-02-18 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise | +6,355 | 154,062 | ||
| 2024-02-18 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −1,869 | $32.18 | $60K | 152,193 |
Page 28 of 41 · 804 trades